To save content items to your account,
please confirm that you agree to abide by our usage policies.
If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account.
Find out more about saving content to .
To save content items to your Kindle, first ensure no-reply@cambridge.org
is added to your Approved Personal Document E-mail List under your Personal Document Settings
on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part
of your Kindle email address below.
Find out more about saving to your Kindle.
Note you can select to save to either the @free.kindle.com or @kindle.com variations.
‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi.
‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.
Acute myeloid leukemia (AML) is a group of clonal malignancies of the bone marrow and peripheral blood. Advances in our understanding of the genetic abnormalities responsible for the development of AML together with the rapidly evolving development of therapeutics that specifically target the underlying genetic lesions have necessitated further refinements in the classification of AML. This is reflected in the recently published International Consensus Classification of AML in which genetically based categorization of AMLs is incorporated to a greater extent than in previous World Health Organization classification schemes, with the goals of improving diagnostic precision, providing more meaningful prognostic information and identifying those patients for whom targeted therapeutics may be beneficial. Genetically defined AMLs account for a higher percentage of cases in children than in adults, and some AML subtypes occur solely in children. This chapter provides an overview of childhood AML, with an emphasis on those entities that are more common or restricted to the pediatric population. Discussion of each AML subtype includes a summary of the molecular pathogenesis and description of the relevant clinical, laboratory, pathologic, and molecular diagnostic features, with an emphasis on differential diagnosis and appropriate utilization of ancillary testing during the diagnostic workup of pediatric AML.
Mixed-phenotype acute leukemia (MPAL) comprises acute leukemias with discrete admixed populations of myeloid and lymphoid blasts (bilineal or mixed lineage) or with coexpression of lymphoid and myeloid markers in a single blast population (biphenotypic or mixed phenotype). However, the distinctions between mixed-lineage and mixed-phenotype MPAL are not always clear-cut. This chapter focuses on explaining the diagnostic criteria for MPAL and lineage-defining markers, summarizing its biological and genetic features, and addressing common diagnostic pitfalls of these unusual leukemias as part of the differential diagnostic considerations.
This chapter covers initial diagnosis of B-lymphoblastic leukemia (B-ALL), and measurable disease detection (MRD) post therapy by flow cytometry. The classic and variant immunophenotypic features of B-ALL are illustrated, correlated with molecular genetic characteristics, and summarized in a genotype-phenotype table. The key features are provided in the differential diagnosis of B-ALL with aberrant MPO versus mixed B/myeloid acute leukemia (MPAL), as well as B-ALL with a mature phenotype versus high grade B cell lymphoma. Under B-ALL MRD detection, the common immunophenotypic alterations are demonstrated by comparing them to normal immature B cells (hematogones). Strategies for MRD detection post targeted therapy are also discussed. The pros and cons of flow cytometry MRD are compared with molecular MRD, including NGS sequencing (Clonoseq) and BCR::ABL1 quantitative PCR. The challenges, including loss of lineage markers, lineage switch, and normal mimics, are discussed and illustrated under diagnostic pitfalls.
Recommend this
Email your librarian or administrator to recommend adding this to your organisation's collection.